| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/12/2008 | EP1895999A1 Use of non-steroidal progesterone receptor modulators |
| 03/12/2008 | EP1895997A2 Use of dna-pk inhibition to sensitise atm deficient cancers to dna-damaging cancer therapies |
| 03/12/2008 | EP1895990A2 Formulations containing pantoprazole free acid and its salts |
| 03/12/2008 | EP1895989A2 A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids |
| 03/12/2008 | EP1895985A1 Morphine sulphate formulations |
| 03/12/2008 | EP1895984A2 Nanoparticulate imatinib mesylate formulations |
| 03/12/2008 | EP1895966A1 Method of extracting ginsengnoside rg2m, pharmaceutical composition including ginsengnoside rg2, and uses thereof |
| 03/12/2008 | EP1895960A1 Transdermal delivery of cannabinoids |
| 03/12/2008 | EP1895849A1 Methods for treatment of beta-amyloid protein-induced ocular disease |
| 03/12/2008 | EP1895843A2 Micogel topical formulations |
| 03/12/2008 | EP1895842A2 Methods and compositions for enhancing immune memory by blocking intrahepatic activated t cell deletion |
| 03/12/2008 | EP1895840A2 P2y6 receptor agonists for treating lung diseases |
| 03/12/2008 | EP1845983A4 Ophthalmic compositions and methods of using the same |
| 03/12/2008 | EP1771157B1 Multiparticle pharmaceutical dosage form for low-soluble active substances and method for producing said pharmaceutical dosage form |
| 03/12/2008 | EP1768602A4 Combination drug therapy for reducing scar tissue formation |
| 03/12/2008 | EP1763515B1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 03/12/2008 | EP1758567A4 Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye |
| 03/12/2008 | EP1745780A4 Medicinal preparation |
| 03/12/2008 | EP1732556B1 Process for the preparation of 3-amino-8-(1-piperazinyl)-2h-1-benzopyran-2-one and salts and hydrates thereof |
| 03/12/2008 | EP1708713B1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 03/12/2008 | EP1697345B1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 03/12/2008 | EP1689390A4 Methods and reagents for the treatment of inflammatory disorders |
| 03/12/2008 | EP1686972B1 Sprayable composition for the administration of vitamin d derivatives |
| 03/12/2008 | EP1682162B1 Use of prickly pear (opuntia) for the preparation of a medicament for the treatment of depressions |
| 03/12/2008 | EP1663993B1 Guanidine derivatives |
| 03/12/2008 | EP1656355B1 Piperazine derivatives and methods of use |
| 03/12/2008 | EP1648440B1 Semi-solid formulations for the oral administration of taxoids |
| 03/12/2008 | EP1641799B1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
| 03/12/2008 | EP1622612B1 Pharmaceutical formulation of the sodium salt of telmisartan |
| 03/12/2008 | EP1617832B1 Compositions for affecting weight loss |
| 03/12/2008 | EP1613596B1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 03/12/2008 | EP1587799B1 Benzoxazole derivatives and their use as adenosine receptor ligands |
| 03/12/2008 | EP1581229B1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 03/12/2008 | EP1578738B1 Escitalopram hydrobromide and a method for the preparation thereof |
| 03/12/2008 | EP1562613B1 Nadh/nadph-containing compound |
| 03/12/2008 | EP1562565B1 Use of one or more elements from the group containing yttrium, neodymium and zirconium |
| 03/12/2008 | EP1560815B1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | EP1524967B1 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
| 03/12/2008 | EP1519721B1 Polymer affinity matrix, a method for the production and use thereof |
| 03/12/2008 | EP1495009B1 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 03/12/2008 | EP1494654B1 Palatable chewable tablet |
| 03/12/2008 | EP1450775B1 C-kit inhibitors for treating bacterial infections |
| 03/12/2008 | EP1450751B1 Nanoparticle delivery vehicle |
| 03/12/2008 | EP1444346B1 Sirna knockout assay method and constructs |
| 03/12/2008 | EP1434590B1 Method for inhibiting the formation of seromas using factor xiii |
| 03/12/2008 | EP1427395B1 Stabilization of active agents by formulation into nanoparticulate form |
| 03/12/2008 | EP1416935B1 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives |
| 03/12/2008 | EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/12/2008 | EP1411986B1 Composition comprising epigallocatechin gallate |
| 03/12/2008 | EP1408999B1 Compositions addressing inflammation and/or degenerative disorders |
| 03/12/2008 | EP1404675B1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes |
| 03/12/2008 | EP1307194B1 Fentanyl composition for nasal administration |
| 03/12/2008 | EP1220680B1 Echinacea supplement and method of manufacture |
| 03/12/2008 | EP1178803B1 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/12/2008 | EP1128830B1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| 03/12/2008 | EP1107730B1 Medicated chewing gum delivery system for nicotine |
| 03/12/2008 | CN201033171Y Medicine label for treating arthralgia |
| 03/12/2008 | CN101142482A Regulators of protein misfolding and aggregation and methods of using the same |
| 03/12/2008 | CN101142321A Methods and compositions for treating ocular disorders |
| 03/12/2008 | CN101142227A Novel betulin derivatives, preparation thereof and use thereof |
| 03/12/2008 | CN101142226A Tricyclic-nucleoside prodrugs for treating viral infections |
| 03/12/2008 | CN101142225A Macrolides with anti-inflammatory activity |
| 03/12/2008 | CN101142219A Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof |
| 03/12/2008 | CN101142218A Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 03/12/2008 | CN101142217A 咪唑并哒嗪化合物 Imidazopyridazine compounds |
| 03/12/2008 | CN101142215A Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 03/12/2008 | CN101142214A Ocaperidone salts and pharmaceutical compositions containing the same |
| 03/12/2008 | CN101142209A Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 03/12/2008 | CN101142208A 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication |
| 03/12/2008 | CN101142203A Novel coumarin derivatives as ion channel openers |
| 03/12/2008 | CN101142202A Anticancer compound, intermediate therefor, and processes for producing these |
| 03/12/2008 | CN101142201A Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 03/12/2008 | CN101142200A Addition salts of tolperisone, processes for their preparation and use thereof |
| 03/12/2008 | CN101142199A [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and N A D P H quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in |
| 03/12/2008 | CN101142198A Isoxazole combretastatin derivatives for the treatment of proliferative disorders |
| 03/12/2008 | CN101142197A N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 03/12/2008 | CN101142196A Ligands for G-protein coupled receptors |
| 03/12/2008 | CN101142195A Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of C N S disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates |
| 03/12/2008 | CN101142194A Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 03/12/2008 | CN101142193A Propane-1,3-dion derivative or salt thereof |
| 03/12/2008 | CN101142192A 1,2-diphenyl-imidazole derivatives and their use as CB1 receptor ligands |
| 03/12/2008 | CN101142191A Process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide |
| 03/12/2008 | CN101142189A 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 03/12/2008 | CN101142188A 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 03/12/2008 | CN101142185A Indoles useful in the treatment of inflammation |
| 03/12/2008 | CN101142183A Mitotic kinesin inhibitors |
| 03/12/2008 | CN101142182A Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as MAOB inhibitors |
| 03/12/2008 | CN101142180A Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 03/12/2008 | CN101142174A Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 03/12/2008 | CN101142172A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 03/12/2008 | CN101142167A Compounds that stimulate glucose utilization and methods of use |
| 03/12/2008 | CN101141982A Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen |
| 03/12/2008 | CN101141972A Gastrointestinal drug composition |
| 03/12/2008 | CN101141971A Stabilised plant extract and its therapeutic use |
| 03/12/2008 | CN101141970A Use of 5'-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection |
| 03/12/2008 | CN101141969A Systems and methods for delivery of peritoneal dialysis (pd) solutions |
| 03/12/2008 | CN101141968A Treatment of a condition in a mammal with administration of compounds and methods of use |
| 03/12/2008 | CN101141967A Novel use of ligands specific to fex-2 polypeptide |